Last Posted: Feb 16, 2020
- Combining clinical and candidate gene data into a risk score for azathioprine-associated leukopenia in routine clinical practice
P Anandi et al, The Pharmacogenomics Journal, February 14, 2020 - [Perspectives of the use of pharmacogenetic tests in neurology and psychiatry].
Kostyuk G P et al. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2019 119(9) 131-135 - Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data.
Roche-Lima Abiel et al. Frontiers in pharmacology 2019 101550 - Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism.
Cornett Elyse M et al. Current oncology reports 2020 Feb 22(2) 18 - Use of pharmacogenetic data to guide individualized opioid prescribing after surgery.
Rocco Raffaele et al. Surgery 2019 166(4) 476-482 - Pharmacogenomics: An evolving clinical tool for precision medicine.
Hockings Jennifer K et al. Cleveland Clinic journal of medicine 2020 Feb 87(2) 91-99 - Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches.
Lin Eugene et al. International journal of molecular sciences 2020 Feb 21(3) - Pharmacogenomic landscape of VIP genetic variants in Jordanian Arabs and comparison with worldwide populations.
Al-Eitan Laith N et al. Gene 2020 Jan 144408 - A precision medicine–based strategy for a severe adverse drug reaction
MR Mack et al, Nature Medicine, February 3, 2020 - Drug Use in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines from CPIC or DPWG for CYP2D6 and CYP2C19 Drug-Gene Pairs: Perspectives for Introducing PGx Test to Polypharmacy Patients.
Westergaard Niels et al. Journal of personalized medicine 2020 Jan 10(1)
.jpeg)
No hay comentarios:
Publicar un comentario